US Imposes 100% Drug Tariff; ICE Courtroom Video

Video from a New York immigration courthouse shows ICE agents ripping an asylum-seeker’s husband from his family and violently slamming the woman, Keila Moreta‑Galarza, to the ground; she required hospital treatment. President Donald Trump announced steep tariffs taking effect Oct. 1, 2025, including a 100% duty on imported branded and patented pharmaceuticals alongside large levies on furniture and heavy trucks, as part of a broader trade package aimed at boosting U.S. manufacturing and reducing the deficit. The administration says generics are largely exempt and that the 100% drug tariff will not apply if a company is “building” a U.S. manufacturing plant by Oct. 1 (previously described as breaking ground or under construction), and some trade deals—most notably with the EU—could blunt the scope, but detailed rules and legal rationale remain unclear. Financial markets and industry groups reacted sharply: major pharma stocks and ETFs plunged, drugmakers warned the move could raise consumer prices, curb R&D and prompt factory closures or layoffs (including hits to New Jersey life‑sciences jobs), and contract manufacturers and exporters in countries such as India and Germany face particular exposure. The announcement undercut prior U.S. trade officials’ statements that no new tariffs were planned and arrives amid an ongoing Section 232 probe and potential legal challenges, leaving the ultimate economic and policy impacts uncertain.